BILL vs KLRS
Bill Com Holdings Inc (BILL) versus Kalaris Therapeutics, Inc. (KLRS) — a side-by-side from cached financials, not a winner call.
Bill Com Holdings Inc (BILL) is a software - application company listed on US.
Kalaris Therapeutics, Inc. (KLRS) is a biotechnology company listed on US.
Latest reported BILL revenue for 2026-06-30 was $1.65B. Net income was -$11.2M. Revenue was up 13.0% from 2025-06-30 to 2026-06-30. BILL currently screens at market cap $4.78B.
KLRS does not have a complete income-statement cache yet.
BILL currently screens at market cap $4.78B. KLRS currently screens at market cap $0.
Not investment advice. Open the BILL and KLRS stock pages for the full models.
Not investment advice.